- Home
- RVSN vs KTTA Comparison
RVSN vs KTTA Comparison
Compare RVSN & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSN
- KTTA
- Stock Information
- Founded
- RVSN 2016
- KTTA 2020
- Country
- RVSN Israel
- KTTA United States
- Employees
- RVSN N/A
- KTTA N/A
- Industry
- RVSN
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- RVSN
- KTTA Health Care
- Exchange
- RVSN Nasdaq
- KTTA Nasdaq
- Market Cap
- RVSN 6.6M
- KTTA 5.5M
- IPO Year
- RVSN 2022
- KTTA 2021
- Fundamental
- Price
- RVSN $0.33
- KTTA $0.69
- Analyst Decision
- RVSN
- KTTA
- Analyst Count
- RVSN 0
- KTTA 0
- Target Price
- RVSN N/A
- KTTA N/A
- AVG Volume (30 Days)
- RVSN 585.9K
- KTTA 130.6K
- Earning Date
- RVSN 08-29-2025
- KTTA 08-12-2025
- Dividend Yield
- RVSN N/A
- KTTA N/A
- EPS Growth
- RVSN N/A
- KTTA N/A
- EPS
- RVSN N/A
- KTTA N/A
- Revenue
- RVSN $1,300,000.00
- KTTA N/A
- Revenue This Year
- RVSN $1,861.54
- KTTA N/A
- Revenue Next Year
- RVSN N/A
- KTTA N/A
- P/E Ratio
- RVSN N/A
- KTTA N/A
- Revenue Growth
- RVSN 815.49
- KTTA N/A
- 52 Week Low
- RVSN $0.27
- KTTA $0.67
- 52 Week High
- RVSN $2.72
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- RVSN 44.40
- KTTA 32.12
- Support Level
- RVSN $0.32
- KTTA $0.67
- Resistance Level
- RVSN $0.36
- KTTA $0.77
- Average True Range (ATR)
- RVSN 0.03
- KTTA 0.03
- MACD
- RVSN 0.00
- KTTA 0.01
- Stochastic Oscillator
- RVSN 23.82
- KTTA 17.53
About RVSN Rail Vision Ltd.
Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).